The market turbulence also affected all sectoral indices, with Nifty Realty index losing 9.4%, Nifty Media falling 8%, and ...

The BSE Smallcap index fell 22 per cent from its peak as broader indices faced significant selling pressure this week due to ...

In the API segment, Natco has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides.Natco Pharma is also ...

All the sectoral indices ended in the red this week with Nifty Realty index shed 9.4 percent, Nifty Media fell 8 percent, ...

Elara sees the ongoing weakness as an opportunity to buy into the pharma space, as it expects robust earnings growth ahead at ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated ... medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 3568.90 Cr. and Equity Capital is Rs. 35.80 Cr ...

Natco Pharma Ltd. key Products/Revenue Segments include Pharmaceuticals, Agrochemicals, Export Incentives, Other Operating Revenue, Scrap for the year ending 31-Mar-2024.For the quarter ended ...

On the political front it is expected that BJP will announce the chief ministerial candidate in the coming week and will take ...

Nagaraj Shetti, Technical Research Analyst at HDFC Securities, believes Monday's pattern could be considered as a High Wave, ...

Natco Pharma Ltd share price was down by -9.42% from the previous closing price of ₹975.05. Who are peers of Natco Pharma Ltd? The peers of Natco Pharma Ltd are Sun Pharmaceuticals Industries ...

The Swiss National Council's Social Security and Health Committee (SGK-N) has proposed a draft for a federal law that seeks to regulate the cultivation, production, trade, and consumption of cannabis ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.